Skip to main content
Premium Trial:

Request an Annual Quote

Avestha Gengraine, Ranbaxy Pen Drug-Discovery Deal

NEW YORK, Sept. 6 (GenomeWeb News) - Avestha Gengraine Technologies, a bioinformatics company based in India, will help Ranbaxy Laboratories develop recombinant cell lines as part of a drug-discovery program, the companies said today.

 

Avestha Gengraine's research covers infectious diseases and degenerative and metabolic disorders.

 

As GenomeWeb News reported late last month, Indian industrial conglomerate Godrej group made an investment in Bangalore-based Avestha Gengraine, according to a media repor.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.